Coverage
-
October 22, 2013
A New Jersey federal judge on Monday tossed a consolidated putative class action against Columbia Laboratories Inc., saying there's no proof behind the allegation that the company knew Prochieve, its drug for preventing premature birth, wouldn't secure regulators' approval, yet misled investors about the drug's prospects.
2 other articles on this case.
View all »